Hybio Pharmaceutical Co., Ltd. (SHE:300199)

China · Delayed Price · Currency is CNY

21.43

+0.85 (4.13%)

Jun 9, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medicine Manufacturing	966.35M	590.20M	431.38M	704.32M	735.97M
Medicine Manufacturing Growth	63.73%	36.82%	-38.75%	-4.30%	1.97%
Total	966.35M	590.20M	431.38M	704.32M	735.97M
Total Growth	63.73%	36.82%	-38.75%	-4.30%	1.97%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	367.93M	265.02M	319.17M	625.06M	689.03M
China Growth	38.83%	-16.97%	-48.94%	-9.28%	1.37%
Foreign	598.42M	325.18M	112.21M	79.26M	46.94M
Foreign Growth	84.03%	189.79%	41.58%	68.86%	11.66%
Total	966.35M	590.20M	431.38M	704.32M	735.97M
Total Growth	63.73%	36.82%	-38.75%	-4.30%	1.97%

Source: S&P Global Market Intelligence.